Switzerland· 70157001
Lanreotid Advanz Pharma 60 mg, Depot-Injektionslösung in einer Fertigspritze
A lanreotide product containing lanreotidum, registered in Switzerland by Advanz Pharma Specialty Medicine Switzerland GmbH and dispensed under Swissmedic category A. The same ATC class is registered in 17 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Lanreotide is registered in 17 of 19 countries.
Countries holding a registration under ATC H01CB03 (lanreotide), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 10 of them publish a price we can compare per daily dose
Lanreotide · ATC H01CB03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lanreotide costs, country by country.
Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.
- Switzerland: $44.46 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Lanreotide · price per daily dose (3 mg)
USD · FX 28 Sept 2026
- FR France$53.80
- CH Switzerland$44.46
The record
At a glance
Swissmedic (Switzerland)- Active substance
- lanreotidum
- Manufacturer
- Advanz Pharma Specialty Medicine Switzerland GmbH
- Country
- Switzerland (CH)
- ATC code
- H01CB03
- ATC class
- Lanreotide
- Defined daily dose
- 3 mg, P
- Swissmedic category
- A
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
157 interactions on record for lanreotide.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lanreotide · interactions on record
157 records
- 2 severe
- 151 moderate
- 4 minor
Most severe, free to view
- LonafarnibA16AX20severe
- PexidartinibL01EX15severe
- LiraglutidA08AX02moderate
- SemaglutidA08AX03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lanreotide in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenLanreotid Amdipharm 60 mg Injektionsvätska, lösning i förfylld sprutaAmdipharm Limited
- PolandLanreotide RanbaxyRanbaxy (Poland) Sp. z o.o.
- NorwayIpstyl AutogelInstitut Produits Synthèse (IPSEN) AB
- SpainLANREOTIDA SUN 60 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFGSun Pharmaceutical Industries (Europe) B.V.
- ItalyIPSTYLIPSEN S.P.A.
- BelgiumLanreotide Viatris 60 mgViatris GX
- NetherlandsLanreotide SUN 120 mg oplossing voor injectie in een voorgevulde spuitSun Pharmaceutical Industries Europe B.V.
- United KingdomLanreotide 120mg/0.5ml solution for injection pre-filled syringesA A H Pharmaceuticals Ltd
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Lanreotid Sun Pharma, Lanreotid Viatris
- Belgium · Lanreotide Sun, Lanreotide Viatris
- Cyprus · Somatuline Autogel
- Czechia · Lanreotid Sun, Lanreotid Zentiva
- Germany · Lanreotid Sun, Lanreotid Viatris
- Denmark · Ipstyl Autogel, Lanreotid Amdipharm Limited
- Estonia · Myrelez, Somatuline Autogel
- Spain · Lanreotida Sun, Lanreotida Zentiva
- Finland · Lanreotid Sun, Lanreotid Zentiva
- France · Lanreotide L.P. Biogaran, Lanréotide Viatris Lp
- United Kingdom (Northern Ireland) · Lanreotide Mylan, Lanreotide Zentiva
- Greece · Lanrod, Myrelez
- Hungary · Lanreotid Sun, Somatuline Autogel
- Ireland · Lanreotide Sun, Lanreotide Viatris
- Italy · Ipstyl, Lanrenet
- Lithuania · Myrelez, Somatuline Autogel
- Luxembourg · Somatuline Autogel Injectable, Somatuline Autogel Injectable120
- Latvia · Myrelez, Somatuline Autogel
- Netherlands · Lanreotide Sun, Mytolac
- Norway · Ipstyl Autogel, Lanreotid Sun
- Poland · Lanreotide Zentiva, Myrelez
- Portugal · Myrelez, Somatulina Autogel
- Romania · Lanreotidă Terapia, Lanreotidă Zentiva
- Sweden · Lanreotid Amdipharm, Lanreotid Sun
- Slovenia · Somatuline Autogel
- Slovakia · Lanreotid Sun, Lanreotid Zentiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a6a80f0d-506f-4dd3-9424-94c8b9f53a38 GET /v1/drugs/a6a80f0d-506f-4dd3-9424-94c8b9f53a38?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about lanreotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.